METOCLOPRAMIDE and VOMITING

3,129 reports of this reaction

2.0% of all METOCLOPRAMIDE reports

#9 most reported adverse reaction

Overview

VOMITING is the #9 most commonly reported adverse reaction for METOCLOPRAMIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 3,129 FDA adverse event reports linking METOCLOPRAMIDE to VOMITING. This represents approximately 2.0% of all 156,854 adverse event reports for this drug.

Patients taking METOCLOPRAMIDE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING3,129 of 156,854 reports

VOMITING is a less commonly reported adverse event for METOCLOPRAMIDE, but still significant enough to appear in the safety profile.

Other Side Effects of METOCLOPRAMIDE

In addition to vomiting, the following adverse reactions have been reported for METOCLOPRAMIDE:

TARDIVE DYSKINESIA — 13,206 reports
EXTRAPYRAMIDAL DISORDER — 11,629 reports
NERVOUS SYSTEM DISORDER — 7,175 reports
DYSTONIA — 6,661 reports
PAIN — 4,663 reports
NAUSEA — 3,909 reports
ECONOMIC PROBLEM — 3,756 reports
ANXIETY — 3,175 reports
MOVEMENT DISORDER — 2,869 reports
ACTIVITIES OF DAILY LIVING IMPAIRED — 2,759 reports

Other Drugs Associated with VOMITING

The following drugs have also been linked to vomiting in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABALOPARATIDE ABEMACICLIB ACETAMINOPHEN ACETAMINOPHEN 325 MG ACETAMINOPHEN 325MG ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL

Frequently Asked Questions

Does METOCLOPRAMIDE cause VOMITING?

VOMITING has been reported as an adverse event in 3,129 FDA reports for METOCLOPRAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with METOCLOPRAMIDE?

VOMITING accounts for approximately 2.0% of all adverse event reports for METOCLOPRAMIDE, making it a notable side effect.

What should I do if I experience VOMITING while taking METOCLOPRAMIDE?

If you experience vomiting while taking METOCLOPRAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

METOCLOPRAMIDE Full Profile All Drugs Causing VOMITING ANI Pharmaceuticals, Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.